{"id":"isoniazide","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute hepatic failure","Acute hepatitis","Acute nephropathy","Alcoholism","Anemia due to enzyme deficiency","Chronic Hepatic Disease","Diabetes mellitus","Diabetic - poor control","Diabetic peripheral neuropathy","Disease of liver","Gout","Hepatic failure","Jaundice","Nutritional disorder","Peripheral nerve disease","Porphyria","Prolonged-Severe Nausea and Vomiting","Slow acetylator due to N-acetyltransferase enzyme variant"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Myeloperoxidase, Cytochrome P450 3A4, Cytochrome P450 3A5"},"_scrapedAt":"2026-03-28T01:56:54.263Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acute tuberculosis","diseaseId":"acute-tuberculosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Inactive tuberculosis","diseaseId":"inactive-tuberculosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pulmonary tuberculosis","diseaseId":"pulmonary-tuberculosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03057756","phase":"","title":"Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance","status":"COMPLETED","sponsor":"Centre de Recherche Médicale de Lambaréné","startDate":"2015-09-11","conditions":"Multi-drug Resistant Tuberculosis","enrollment":23},{"nctId":"NCT05005637","phase":"PHASE2","title":"The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA","status":"COMPLETED","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2021-08-27","conditions":"Tuberculous Uveitis","enrollment":78},{"nctId":"NCT05534750","phase":"PHASE2","title":"Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-04-20","conditions":"Tuberculosis, Multidrug Resistant Tuberculosis","enrollment":60},{"nctId":"NCT06539455","phase":"","title":"Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stefania Cheli","startDate":"2024-07-05","conditions":"Tuberculosis Infection","enrollment":127},{"nctId":"NCT05073926","phase":"","title":"Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis","status":"RECRUITING","sponsor":"Region Skane","startDate":"2021-09-30","conditions":"Latent Tuberculosis, Staphylococcus Aureus","enrollment":100},{"nctId":"NCT05621343","phase":"","title":"New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis","status":"RECRUITING","sponsor":"Region Skane","startDate":"2021-12-21","conditions":"Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis","enrollment":130},{"nctId":"NCT00771498","phase":"PHASE4","title":"An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin","status":"COMPLETED","sponsor":"Oswaldo Cruz Foundation","startDate":"2008-11","conditions":"HIV Infection, Tuberculosis","enrollment":30},{"nctId":"NCT01222338","phase":"PHASE2","title":"Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients","status":"COMPLETED","sponsor":"Lisichansk Regional Tuberculosis Dispensary","startDate":"2010-01","conditions":"Tuberculosis","enrollment":123},{"nctId":"NCT01158755","phase":"PHASE2","title":"Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2010-10","conditions":"Meningitis, Tuberculous, Pharmacokinetics, Pharmacodynamics","enrollment":60},{"nctId":"NCT00405301","phase":"PHASE4","title":"Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences","startDate":"2006-12","conditions":"Drug Induced Hepatotoxicity, Tuberculosis","enrollment":175},{"nctId":"NCT01342497","phase":"PHASE2","title":"Oral BBR-012 in the Treatment of Diabetic Foot Ulcers, Proof of Concept Study","status":"UNKNOWN","sponsor":"Bridge BioResearch Ltd.","startDate":"2011-07","conditions":"Diabetic Foot Ulcer","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":35,"reaction":"DRUG INEFFECTIVE"},{"count":31,"reaction":"TUBERCULOSIS"},{"count":27,"reaction":"VOMITING"},{"count":23,"reaction":"ARTHRALGIA"},{"count":22,"reaction":"PYREXIA"},{"count":21,"reaction":"DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS"},{"count":20,"reaction":"DIARRHOEA"},{"count":19,"reaction":"ANAEMIA"},{"count":19,"reaction":"HEADACHE"},{"count":19,"reaction":"PRURITUS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_2","status":"active","brandName":"isoniazide","genericName":"isoniazide","companyName":"Bridge BioResearch Ltd.","companyId":"bridge-bioresearch-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Isoniazid is a small molecule antibiotic used for the treatment of tuberculosis, including active and latent forms, as well as multidrug-resistant tuberculosis. It is typically taken orally, but may also be administered by injection, and is often used in combination with other medications such as rifampicin, pyrazinamide, and either streptomycin or ethambutol.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}